블로그
-
[Philippines FDA] FDA Advisory No.2026-0781|| Product Recall of Specific Batch of Nicardipine Hydroc
FDA Advisory No.2026-0781|| Product Recall of Specific Batch of Nicardipine Hydrochloride 1 mg/mL Solution ) that the affected batch of the pharmaceutical product is being recalled from the market.
blog.naver.com · 2026.07.16
-
삼천당 S-Pass FDA 허가 경로 분석
from=profile&itemCode=000250&discussionType=domesticStock 작성시점2026.04.07. 23:50조회 327 오늘 PRE-ANDA 미팅 승인 뉴스 계기로, S-Pass FDA 허가 경로 정리해봄. 1.
blog.naver.com · 2026.04.07
-
초음속 미사일 잡는 아스터 30 지대공, 함대공 미사일 - 안팔레옹에서 발사된 MICA 초음속 공대공 미사일 잡는 영상
Welcome > Defense > The frigate "Alsace" fired an Aster 30 missile at a "supersonic target" sent from the Red Sea, the French Navy's frigate "Alsace" this time shot down a "supersonic target" launched from
blog.naver.com · 2025.10.11
-
Registration of Biocide Products - #2. Europe
This week, we will be stepping away from USA and talk more about Europe’s way of registering biocidal Quite contrary to US’ EPA and FDA, Europe’s European Chemical Agency (ECHA) handles bioc.......
blog.naver.com · 2022.05.11
-
CTD 가이드라인 정리 (from FDA)
https://www.fda.gov/media/71551/download
blog.naver.com · 2020.10.22
-
Regulatory Action Against Ranbaxy
Press Release1: FDA prohibits Ranbaxy’s Toansa, India facility from producing and distributing drugs for Mohali, India, Facility FDA Press Release3: FDA prohibits manufacture of FDA-regulated drugs from
blog.naver.com · 2014.03.10
-
FDA Issues Warning Letters to Ranbaxy Laboratories Ltd.,
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm News & Events FDA NEWS FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy
blog.naver.com · 2014.03.10